2025 Was Not About Breakthroughs. It Was About Convergence. If 2024 was about proving the possibility of new healthcare ideas, 2025 marked the year that these innovations, across biotech, genomics, diagnostics, digital...read more
Category - Genomic medicine
Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues
Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
Rewiring Precision Medicine: How AI Is Transforming Science and Business
Artificial intelligence is transforming every link in the precision medicine value chain. From drug discovery and manufacturing to supply chain optimization and laboratory operation, AI’s impact is both deep and...read more
Dozens of states sue to block the sale of 23andMe personal genetic data without customer consent
PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit...read more
